FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Boceprevir (VICTRELIS) Capsules
Status: Discontinuation
»Therapeutic Categories:

Merck Sharp & Dohme Corp. (New 01/20/2015)

Company Contact Information:

Presentation Posting Date Related Information
200 mg Capsules (NDC 00085-0314-02) 01/20/2015 Estimated product availability until December 2015. The product discontinuation is not related to product safety or efficacy.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English